Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 42708-034

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 42708-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

42708 034 30

42708 034 30
Label from a bottle of Lisinopril and Hydrochlorothiazide Tablets USP, 10 mg/12.5 mg, containing 30 tablets. The label displays the NDC 42708-034-30, manufacturer's name QPharma Inc, medication usage instructions blanks, and storage directions to keep the container tightly closed at controlled room temperature. The label is marked as a sample not for sale and indicates Rx only.*
FDA Label Image

Image 1

Image 1
Chemical structure of lisinopril is shown, depicting its molecular framework including amine, carboxyl, and benzene ring groups, with two water molecules (dihydrate) indicated.*
FDA Label Image

Image 2

Image 2
Chemical structure diagram showing a sulfonamide compound with chlorine and sulfone groups, consistent with the active ingredient hydrochlorothiazide in the combination drug Lisinopril and Hydrochlorothiazide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.